SCHEMBL276427

SCHEMBL276427

CCCC(CC)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18664252 1.00
SCHEMBL20145272 1.00
Hydrochloric Acid SCHEMBL17748959 0.97 CA2 (0.71)
Methane SCHEMBL28580672 0.97 CA2 (0.71)
SCHEMBL14571349 0.95 CA2 (0.68)
Sulfuric Acid SCHEMBL28583675 0.91 CA2 (0.63)
Formic Acid SCHEMBL28659958 0.91 CA2 (0.63)
Valpromide SCHEMBL35392 0.89 CA2 (0.58)
SCHEMBL28370065 0.89 CA2 (0.61)
SCHEMBL13375642 0.88 CA2 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 475 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118119609-A Imidazole derivatives and their use as antibiotics 豪夫迈·罗氏有限公司 2024-05-31 CN claimed
CN-118076594-A Sulfonylpiperazinyl compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-05-24 CN claimed
CN-117794896-A Protease inhibitors for the treatment of coronavirus infections 斯克里普斯研究学院 2024-03-29 CN claimed
CN-117715892-A Quaternary ammonium cation substituted compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-03-15 CN claimed
EP-4322935-A1 AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION Rhea Innovations S.R.L. (IT) 2024-02-21 EP claimed
EP-4236691-A1 COMPOSITIONS COMPRISING MEFENTRIFLUCONAZOLE BASF Agro B.V. (NL) 2023-09-06 EP claimed
CN-111601798-B Bisamide sarcomere activating compounds and uses thereof 美国安进公司 2023-08-11 CN claimed
CN-116390727-A N-linked isoquinolinamides as LRRK2 inhibitors, pharmaceutical compositions and uses thereof 默沙东有限责任公司 2023-07-04 CN claimed
CN-116096709-A Novel heterocyclic antibiotics 豪夫迈·罗氏有限公司 2023-05-09 CN claimed
CN-115989225-A Imidazole-pyrazole derivatives as antibacterial agents 豪夫迈·罗氏有限公司 2023-04-18 CN claimed
WO-2018220020-A2 RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE L'OREAL (FR) 2018-12-06 WO claimed
EP-3371163-A1 PYRROLIDINE DERIVATIVES Hua Medicine (Shanghai) Ltd. (CN) 2018-09-12 EP claimed
WO-2017071536-A1 PYRROLIDINE DERIVATIVES HUA MEDICINE (SHANGHAI) LTD. (CN) 2017-05-04 WO claimed
WO-2013175395-A2 IMPROVED PROCESS FOR PREPARATION OF SAXAGLIPTIN AND ITS SALTS DR. REDDYS LABORATORIES LIMITED (IN) 2013-11-28 WO claimed
US-20120238582-A1 QUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-09-20 US claimed
US-8242289-B2 Alkyl-substituted tetrahydropyrans as flavoring substances SYMRISE AG (DE) 2012-08-14 US claimed
EP-2168957-B1 Alkyl-substituted tetrahydropyranes as aromatic materials SYMRISE AG (DE) 2012-02-15 EP claimed
US-20100226864-A1 ALKYL-SUBSTITUTED TETRAHYDROPYRANS AS FLAVORING SUBSTANCES SYMRISE GMBH & CO. KG (DE) 2010-09-09 US claimed
EP-1329487-B1 Use of aqueous ink-jet inks for printing on commercial offset coated media HEWLETT PACKARD CO (US) 2006-11-22 EP claimed
CN-1791401-A Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof BRISTOL MYERS SQUIBB CO (US) 2006-06-21 CN claimed